Rights and permissions
About this article
Cite this article
Infliximab worth it for Crohn's disease in the UK. Pharmacoecon. Outcomes News 491, 6 (2005). https://doi.org/10.2165/00151234-200504910-00008
Published:
Issue Date:
DOI: https://doi.org/10.2165/00151234-200504910-00008